Abstract Library

#2278 Incidental Histological Diagnosis of Small Pancreatic Neuroendocrine Tumors: Are We Underestimating Their Incidence?

Introduction: The annual incidence of pancreatic neuroendocrine tumours (PanNET) has been estimated to be around 0.8/100,000 inhabitants.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Giannone F

Authors: Giannone F, Partelli S, Muffatti F, Balzano G, Crippa S,

Keywords: incidentaloma, microadenoma,

#2228 Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Non Functioning Pancreatic Neuroendocrine Tumors: Outcome Analysis from 378 Consecutive Resections in a High-Volume Institution

Introduction: The optimal management of regional lymph nodes during resections of Pancreatic Neuroendocrine Tumors (pNETs) remains controversial. Conflicting data exist on predictors of LN metastases (LNM) and their impact on survival

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Malpaga A, Miotto M, Elio G, Nessi C, Pollini T,

Keywords: Pancreatic NET, Lymphadenectomy, N status, Surgery,

#2045 Perioperative Outcomes of Surgery for Pancreatic Neuroendocrine Neoplasms in Germany

Introduction: The incidence of pancreatic neuroendocrine neoplasms(pNEN) is increasing and the perioperative outcomes of specialized centers are favourable.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Mintziras I, Werner J, Keck T, Hommann M, Germer C,

Keywords: pancreatic neuroendocrine neoplasms, surgical resection, StuDoQ|pancreas registry,

#973 Toward a Preoperative Classification of Mesenteric Lymph Node Metastases for Better Selection of Carcinoid Tumors Before Radical Surgery

Introduction: Surgery for small bowel carcinoid (SBC) and lymph node (LN) metastases, when technically possible, represents the best therapy. However, surgical challenge is (i) not to recuse patients for false unresectable mesenteric artery invasion, and/or (ii) to avoid extensive small bowel resection.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Deguelte-Lardière S

Authors: Deguelte-Lardière S, Cadiot G, Appere F, Noaves M, Hentic O,

Keywords: carcinoid tumor, surgical procedures,

#591 Pancreastatin: A Predictive Neuroendocrine Tumor Marker

Introduction: Pancreastatin is a derived peptide of CgA. Pancreastatin has the potential to be a diagnostic and predictive tumor marker in detecting NETs.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Rustagi S, Warner R, Divino C,

Keywords: pancreastatin, NETs, CgA,